Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 281Head and Neck Neoplasms 258Nasopharyngeal Carcinoma 127Oropharyngeal Neoplasms 57Carcinoma, Squamous Cell 54Nasopharyngeal Neoplasms 41Laryngeal Neoplasms 35Mouth Neoplasms 30Hypopharyngeal Neoplasms 29Carcinoma 24Salivary Gland Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Tongue Neoplasms 15Neoplasm Metastasis 13Laryngeal Diseases 13Recurrence 12Neoplasms 10Parkinson Disease 4, Autosomal Dominant Lewy Body 8Mucositis 8Stomach Neoplasms 7Pharyngeal Neoplasms 7Papillomavirus Infections 7Ovarian Neoplasms 7Lung Neoplasms 7Radiation Injuries 6Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Esophageal Neoplasms 6Colorectal Neoplasms 6Thyroid Neoplasms 5

Interventions

toripalimab 1Radiotherapy 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Cisplatin × Head & Neck × Clear all
NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡